Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by skyhigh123on May 02, 2018 2:30pm
286 Views
Post# 27971700

Prometic —- Boehringer ?Wouldn’t that be a great team $$$$$

Prometic —- Boehringer ?Wouldn’t that be a great team $$$$$

Plasminogen Market Top Manufacturers by 2023: Boehringer ...

The Mobile Herald-Apr. 23, 2018
The global Plasminogen market statistical surveying report tracks huge realities related with business confinements and procedures that include innovative progression Plasminogenacquisitions, and mergers, presentation, an introduction of new products, different business details of the Plasminogen .

Sky
Bullboard Posts